<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Jameshebrew - Latest News</title>
<link href="https://news.press-release-wire.com/rss/jameshebrew/latest.xml"></link>
<updated>2026-07-19T15:22:40+00:00</updated>
<id>urn:uuid:05a9f158-0bd1-2190-0654-c78a08334acc</id>
<entry>
<title>Human Microbiome Market, 2019-2030 by Roots Analysis</title>
<link href="https://news.press-release-wire.com/@jameshebrew/human-microbiome-market-2019-2030-by-roots-analysis-rnwqn3y4x7p3"></link>
<id>urn:uuid:29e998e5-16ad-0b20-c23e-d2db41710b3c</id>
<summary type="html"><![CDATA[Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future]]></summary>
<updated>2021-09-02T09:18:58+00:00</updated>
</entry>
<entry>
<title>Patient Recruitment and Retention Services Marker, 2019-2030 by Roots Analysis</title>
<link href="https://news.press-release-wire.com/@jameshebrew/patient-recruitment-and-retention-services-marker-2019-2030-by-roots-analysis-jdp755wak7wr"></link>
<id>urn:uuid:74c548c7-c8ff-d86e-8ff3-ef5f80c8ed9b</id>
<summary type="html"><![CDATA[A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers]]></summary>
<updated>2021-09-02T07:21:08+00:00</updated>
</entry>
<entry>
<title>Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market By Rootsanalysis</title>
<link href="https://news.press-release-wire.com/@jameshebrew/liquid-biopsy-and-other-non-invasive-cancer-diagnostics-market-by-rootsanalysis-jp67re6rrq5k"></link>
<id>urn:uuid:a7a608b1-4d0d-f5c0-3f84-e08f7b8bc722</id>
<summary type="html"><![CDATA[Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access]]></summary>
<updated>2021-08-31T05:51:32+00:00</updated>
</entry>
<entry>
<title>Drug Repurposing Service Providers Market, 2020-2030 By Roots Analysis</title>
<link href="https://news.press-release-wire.com/@jameshebrew/drug-repurposing-service-providers-market-2020-2030-by-roots-analysis-rnwqn3nwk7p3"></link>
<id>urn:uuid:6c36cdc3-6dec-45c2-e438-197d7e6ba7f8</id>
<summary type="html"><![CDATA[Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs]]></summary>
<updated>2021-08-31T04:29:39+00:00</updated>
</entry>
<entry>
<title>Elastomeric Closure Components Market For Vials, Cartridges and Syringes by Roots Analysis</title>
<link href="https://news.press-release-wire.com/@jameshebrew/elastomeric-closure-components-market-for-vials-cartridges-and-syringes-by-roots-analysis-w3d7pwrajqk5"></link>
<id>urn:uuid:61867f26-3c96-c1a8-cfe9-9b8f86bfd923</id>
<summary type="html"><![CDATA[Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential]]></summary>
<updated>2021-08-26T09:28:15+00:00</updated>
</entry>
<entry>
<title>Manufacturing Market Continuous by Roots Analysis</title>
<link href="https://news.press-release-wire.com/@jameshebrew/manufacturing-market-continuous-by-roots-analysis-w3d7pwrmjqk5"></link>
<id>urn:uuid:feac0e2b-90a4-bd72-29da-9e00909f1335</id>
<summary type="html"><![CDATA[Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing]]></summary>
<updated>2021-08-26T07:08:26+00:00</updated>
</entry>
<entry>
<title>The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030</title>
<link href="https://news.press-release-wire.com/@jameshebrew/the-biopharmaceutical-contract-biomanufacturing-market-is-projected-to-be-worth-usd-324-billion-by-2030-mp3q3rr6n7ne"></link>
<id>urn:uuid:f79eb63f-7e49-382f-e320-447908468473</id>
<summary type="html"><![CDATA[Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development programs]]></summary>
<updated>2021-08-13T08:50:41+00:00</updated>
</entry>
<entry>
<title>The CAR-T therapies market is characterized by a healthy pipeline of promising therapies</title>
<link href="https://news.press-release-wire.com/@jameshebrew/the-car-t-therapies-market-is-characterized-by-a-healthy-pipeline-of-promising-therapies-5x8qewww8qdj"></link>
<id>urn:uuid:4031f773-f0b5-198b-8d20-5ee28beebd14</id>
<summary type="html"><![CDATA[Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market]]></summary>
<updated>2021-08-13T05:41:48+00:00</updated>
</entry>
<entry>
<title>The gene therapy market is projected to be worth USD 14.6 billion in 2030,  claims Roots Analysis</title>
<link href="https://news.press-release-wire.com/@jameshebrew/the-gene-therapy-market-is-projected-to-be-worth-usd-146-billion-in-2030-claims-roots-analysis-6xwqwap38qj8"></link>
<id>urn:uuid:f3c249fc-ef39-35a1-8637-d9395ba00d8f</id>
<summary type="html"><![CDATA[Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene therapies pipeline is growing.]]></summary>
<updated>2021-08-03T09:39:06+00:00</updated>
</entry>
<entry>
<title>Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, claims Roots Analysis</title>
<link href="https://news.press-release-wire.com/@jameshebrew/human-microbiome-based-products-market-is-projected-to-be-worth-usd-4-billion-by-2030-claims-roots-analysis-mp3q3r5p57ne"></link>
<id>urn:uuid:90576f1f-fa04-6e84-c69e-6daadf656745</id>
<summary type="html"><![CDATA[Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future]]></summary>
<updated>2021-08-03T09:33:54+00:00</updated>
</entry>
</feed>